Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...

January 2, 2007 — The US Food and Drug Administration (FDA) warned healthcare professionals last week about additional reports of nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy ...

A magnetic resonance imaging (MRI) scan is an important tool to help doctors see what’s happening inside your body. But new, preliminary research suggests that a contrast agent used in some MRIs could ...

HOUSTON – (Nov. 17, 2022) – You can keep your best guesses. Engineers at Rice University’s George R. Brown School of Engineering are starting to understand exactly what goes on when doctors pump ...

Physicians routinely prescribe an infusion containing gadolinium to enhance MRI scans, but there is evidence that nanoparticles of the toxic rare earth metal infiltrate kidney cells, sometimes ...

DEAR DR. ROACH: Due to a slight genetic risk of breast cancer (my Tyrer-Cuzick Model score was 20.6%), my doctor wants me to get breast MRIs with contrast annually. I am concerned about long-term ...

The volume of contrast media used for diagnostic imaging, including iodinated and gadolinium agents, has increased in recent years.

Gadopiclenol carries a Boxed Warning associated with an increased risk of nephrogenic systemic fibrosis among patients with impaired elimination of the drugs. The approval of gadopiclenol was based on ...

Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based contrast agent was well ...

New research suggests that MRI with contrast may create nanoparticles that infiltrate your tissues. The research is preliminary, and more work needs to be done. Doctors stress that MRI with contrast ...